Table 2 Antithrombotic treatment strategy in-hospital and at hospital discharge
|  | Overall population (n = 24658) | AF (n = 740) | No AF (n = 23918) | P value |
|---|---|---|---|---|
In-hospitala | ||||
 DAPT | 86.1 | 78.0 | 86.3 | <0.01 |
 UFH | 5.9 | 5.2 | 5.9 | 0.43 |
 LMWH | 84.2 | 84.9 | 84.1 | 0.59 |
 Fondaparinux | 3.8 | 2.9 | 3.9 | 0.16 |
 Warfarin | 1.4 | 3.5 | 1.4 | <0.01 |
At hospital discharge | ||||
 DATP | 85.9 | 76.2 | 86.1 | <0.01 |
 Warfarin | 1.9 | 5.1 | 1.4 | <0.01 |
 Warfarin alone | 0.3 | 1.0 | 0.3 | 0.02 |
 Warfarin + single antiplatelet drug | 0.9 | 2.4 | 0.7 | <0.01 |
 Warfarin + DAPT | 0.7 | 1.7 | 0.5 | <0.01 |